Cadex GenomicsMolecular Diagnostics: A Broken Business Model or Flawed Execution?It is common to hear concerns from investors and other stakeholders about the business case for molecular diagnostics. One life science…Apr 16, 2020Apr 16, 2020
Cadex GenomicsThe Case for Real-Time Cancer Therapy MonitoringMost stage IV cancer patients ultimately die from their disease. For late-stage cancer patients, the primary medical treatment objective…May 10, 2019May 10, 2019